MY336-a, a novel .BETA.-adrenergic receptor antagonist produced by Streptomyces gabonae.

抄録

Streptomyces gabonae KY2234 was found to produce a new compound, MY336-a, which bound to β-adrenergic receptor. The compound was isolated from the fermentation broth of KY2234. MY336-a showed a high affinity for the β-receptor, labeled with [3H]dihydroalprenolol in the membrane fractions of rat heart (β1-adrenergic receptor) or lung (β2-adrenergic receptor), whereas the compound bound very weakly to α-adrenergic receptor, labeled with [3H]dihydroergokryptine in rat brain. The inhibition constants (Ki) of the compound were 0.73 and 0.14 μM for the β-receptors of heart and lung, respectively. 5'-Guanylylimidodiphosphate (Gpp(NH)p) did not alter the affinity of the β-receptors for MY336-a. In isolated guinea-pig atria, MY336-a produced an inhibition of the positive chronotropic and inotropic effects of isoproterenol. MY336-a also antagonized the relaxation of tone induced by isoproterenol in isolated guinea-pig trachea. No partial agonistic activity was detected in MY336-a in the isolated atria and trachea. In anaesthetized dogs, MY336-a (1 mg/kg, iv) exerted negative inotropic action (left ventricular dp/dt max, -32.6%).

収録刊行物

キーワード

詳細情報 詳細情報について

  • CRID
    1390282679126090240
  • NII論文ID
    130003409557
  • DOI
    10.7164/antibiotics.39.354
  • ISSN
    18811469
    00218820
  • PubMed
    2871004
  • 本文言語コード
    en
  • データソース種別
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ